
Arctic Bioscience Investor Relations Material
Latest events

Study Result
Arctic Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Arctic Bioscience
Access all reports
Arctic Bioscience ASA is a biotechnology company specializing in the development and production of health products derived from marine ingredients, particularly omega-3 fatty acids from herring roe. The company's products are used in the nutraceutical and pharmaceutical sectors, offering health benefits related to brain, heart, and immune function. In addition to producing omega-3-based supplements for consumer markets, Arctic Bioscience is involved in the research and development of new pharmaceutical applications utilizing marine-based bioactive compounds. The company is headquartered in Ørsta, Norway, and its shares are listed on the Oslo Stock Exchange.
Key slides for Arctic Bioscience


Q2 2024
Arctic Bioscience


Q4 2023
Arctic Bioscience
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
ABS
Country
🇳🇴 Norway